{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T00:18:01Z","timestamp":1792282681025,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.biomaterials.2015.12.021","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T19:00:18Z","timestamp":1450724418000},"page":"124-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"special_numbering":"C","title":["Intravenous administration of brain-targeted stable nucleic acid lipid particles alleviates Machado-Joseph disease neurological phenotype"],"prefix":"10.1016","volume":"82","author":[{"given":"Mariana","family":"Concei\u00e7\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9vio","family":"N\u00f3brega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lia","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Nuno","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Manjunath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5831-3307","authenticated-orcid":false,"given":"Lu\u00eds","family":"Pereira de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2015.12.021_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1474-4422(04)00737-9","article-title":"Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis","volume":"3","author":"Schols","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrn1474","article-title":"Stefano. Pathways to motor incoordination: the inherited ataxias","volume":"5","author":"Taroni","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng1194-221","article-title":"CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1","volume":"8","author":"Kawaguchi","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0896-6273(00)80943-5","article-title":"Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3","volume":"19","author":"Paulson","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib5","first-page":"17","article-title":"Machado-Joseph disease","volume":"3","author":"Sudarsky","year":"1995","journal-title":"Clin. Neurosci."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib6","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/hmg\/ddn106","article-title":"Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease","volume":"17","author":"Alves","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib7","doi-asserted-by":"crossref","first-page":"e3341","DOI":"10.1371\/journal.pone.0003341","article-title":"Allele-specific RNA silencing of mutant ataxin-3 mediates neuroprotection in a rat model of Machado-Joseph disease","volume":"3","author":"Alves","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib8","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1093\/hmg\/ddq111","article-title":"Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3?","volume":"19","author":"Alves","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib9","doi-asserted-by":"crossref","first-page":"e52396","DOI":"10.1371\/journal.pone.0052396","article-title":"Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice","volume":"8","author":"N\u00f3brega","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib10","doi-asserted-by":"crossref","first-page":"e100086","DOI":"10.1371\/journal.pone.0100086","article-title":"RNA interference mitigates motor and neuropathological deficits in a cerebellar mouse model of Machado-Joseph disease","volume":"9","author":"N\u00f3brega","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib11","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/mt.2013.144","article-title":"Toward RNAi therapy for the polyglutamine disease Machado-Joseph disease","volume":"21","author":"Costa Mdo","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib12","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/mt.2013.152","article-title":"Silencing mutant ATXN3 expression resolves molecular phenotypes in SCA3 transgenic mice","volume":"21","author":"Rodriguez-Lebron","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib13","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/nbt1122","article-title":"Potent and persistent in\u00a0vivo anti-HBV activity of chemically modified siRNAs","volume":"23","author":"Morrissey","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature04688","article-title":"RNAi-mediated gene silencing in non-human primates","volume":"441","author":"Zimmermann","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1021\/bc9004365","article-title":"Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treatment","volume":"21","author":"Mendonca","year":"2010","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib16","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1038\/mtna.2013.30","article-title":"Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment","volume":"2","author":"Costa","year":"2013","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0005-2736(91)90246-5","article-title":"Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in\u00a0vivo","volume":"1066","author":"Allen","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib18","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1021\/bi500021j","article-title":"Interactions of indocyanine green and lipid in enhancing near-infrared fluorescence properties: the basis for near-infrared imaging in\u00a0vivo","volume":"53","author":"Kraft","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib19","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/bit.22858","article-title":"Co-encapsulation of anti-BCR-ABL siRNA and imatinib mesylate in transferrin receptor-targeted sterically stabilized liposomes for chronic myeloid leukemia treatment","volume":"107","author":"Mendonca","year":"2010","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib21","doi-asserted-by":"crossref","first-page":"e11085","DOI":"10.1371\/journal.pone.0011085","article-title":"Liposome-siRNA-peptide complexes cross the blood-brain barrier and significantly decrease PrP on neuronal cells and PrP in infected cell cultures","volume":"5","author":"Pulford","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib23","doi-asserted-by":"crossref","first-page":"11808","DOI":"10.1039\/c2jm31675g","article-title":"Brain-targeting gene delivery using a rabies virus glycoprotein peptide modulated hollow liposome: bio-behavioral study","volume":"22","author":"Tao","year":"2012","journal-title":"J.\u00a0Mater. Chem."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12017-012-8196-8","article-title":"RVG-mediated calpain2 gene silencing in the brain impairs learning and memory","volume":"15","author":"Zadran","year":"2013","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib25","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/bm401906p","article-title":"RVG-peptide-linked trimethylated chitosan for delivery of siRNA to the brain","volume":"15","author":"Gao","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib26","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/mds.25978","article-title":"Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice","volume":"29","author":"Cooper","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biomaterials.2014.10.068","article-title":"Enhanced BBB permeability of osmotically active poly(mannitol-co-PEI) modified with rabies virus glycoprotein via selective stimulation of caveolar endocytosis for RNAi therapeutics in Alzheimer's disease","volume":"38","author":"Park","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib28","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2009.02.051","article-title":"Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles","volume":"30","author":"Liu","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrmicro2260","article-title":"The cell biology of rabies virus: using stealth to reach the brain","volume":"8","author":"Schnell","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib30","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/j.biomaterials.2011.12.017","article-title":"Target delivery of a gene into the brain using the RVG29-oligoarginine peptide","volume":"33","author":"Gong","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/embor.2008.31","article-title":"Lentivector-mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia","volume":"9","author":"Torashima","year":"2008","journal-title":"EMBO Rep."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/nbdi.2001.0388","article-title":"Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease","volume":"8","author":"de Almeida","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1014434732752","article-title":"Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity","volume":"19","author":"Moreira","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11745-006-3013-5","article-title":"The Liebermann-Burchard reaction: sulfonation, desaturation, and rearrangment of cholesterol in acid","volume":"42","author":"Xiong","year":"2007","journal-title":"Lipids"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib35","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/brain\/awr047","article-title":"Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease","volume":"134","author":"Nascimento-Ferreira","year":"2011","journal-title":"Brain a J. neurol."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib36","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/brain\/awu352","article-title":"Transplantation of cerebellar neural stem cells improves motor coordination and neuropathology in Machado-Joseph disease mice","volume":"138","author":"Mendon\u00e7a","year":"2015","journal-title":"Brain a J. neurol."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib37","doi-asserted-by":"crossref","first-page":"13003","DOI":"10.1073\/pnas.97.24.13003","article-title":"The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters","volume":"97","author":"Wender","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib38","doi-asserted-by":"crossref","first-page":"23450","DOI":"10.1074\/jbc.M709387200","article-title":"Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape","volume":"283","author":"El-Sayed","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2013.02.020","article-title":"Octa-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancer","volume":"335","author":"Biswas","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.chembiol.2014.11.009","article-title":"Attachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA","volume":"22","author":"Zeller","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib41","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/brain\/aws177","article-title":"Calpastatin-mediated inhibition of calpains in the mouse brain prevents mutant ataxin 3 proteolysis, nuclear localization and aggregation, relieving Machado\u2013Joseph disease","volume":"135","author":"Sim\u00f5es","year":"2012","journal-title":"Brain a J. neurol."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib42","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0896-6273(00)80798-9","article-title":"Beyond the Dopamine Receptor: the DARPP-32\/Protein Phosphatase-1 Cascade","volume":"23","author":"Greengard","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib43","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1523\/JNEUROSCI.22-09-03473.2002","article-title":"Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length","volume":"22","author":"de Almeida","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib45","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1111\/j.1742-4658.2010.07904.x","article-title":"Efficient and targeted delivery of siRNA in\u00a0vivo","volume":"277","author":"Shim","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib46","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0005-2736(00)00343-6","article-title":"Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures","volume":"1510","author":"Semple","year":"2001","journal-title":"Biochim. Biophys. Acta (BBA) - Biomembr."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib47","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1016\/j.biomaterials.2011.03.047","article-title":"A\u00a0brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA","volume":"32","author":"Hwang do","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib48","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2010.08.011","article-title":"RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain","volume":"155","author":"Son","year":"2011","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.02.003","article-title":"Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics","volume":"203","author":"Lorenzer","year":"2015","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12311-013-0516-5","article-title":"Mutant ataxin-3 with an abnormally expanded polyglutamine chain disrupts dendritic development and metabotropic glutamate receptor signaling in mouse cerebellar Purkinje cells","volume":"13","author":"Konno","year":"2014","journal-title":"Cerebellum"},{"key":"10.1016\/j.biomaterials.2015.12.021_bib51","unstructured":"Concei\u00e7\u00e3o M, Mendon\u00e7a L, N\u00f3brega C, Gomes C, Costa P, Hirai H, et\u00a0al. Safety Profile of the Intravenous Administration of Brain-targeted Stable Nucleic Acid Lipid Particles. Data in Brief. Submitted."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib52","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biomaterials.2015.12.021_bib53","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961215010091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961215010091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:14:52Z","timestamp":1758903292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961215010091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":53,"alternative-id":["S0142961215010091"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2015.12.021","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous administration of brain-targeted stable nucleic acid lipid particles alleviates Machado-Joseph disease neurological phenotype","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2015.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}